Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1968 1
1971 1
1972 1
1974 1
1976 1
1978 1
1980 2
1982 1
1983 2
1984 1
1985 5
1986 2
1987 6
1988 5
1989 9
1990 7
1991 10
1992 6
1993 15
1994 7
1995 10
1996 14
1997 12
1998 17
1999 17
2000 16
2001 16
2002 16
2003 23
2004 28
2005 15
2006 37
2007 41
2008 50
2009 43
2010 36
2011 46
2012 51
2013 59
2014 92
2015 110
2016 148
2017 186
2018 166
2019 135
2020 174
2021 199
2022 225
2023 261
2024 90

Text availability

Article attribute

Article type

Publication date

Search Results

2,148 results

Results by year

Filters applied: . Clear all
Page 1
3-Cyano-4-[(18)F]fluoro-benzoyl-Ala(SO(3)H)-Ala(SO(3)H)-Ava-Gln-Trp-Ala-Val-NMeGly-His-Sta-Leu-NH(2).
Leung K. Leung K. 2011 Jun 5 [updated 2011 Aug 25]. In: Molecular Imaging and Contrast Agent Database (MICAD) [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2004–2013. 2011 Jun 5 [updated 2011 Aug 25]. In: Molecular Imaging and Contrast Agent Database (MICAD) [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2004–2013. PMID: 21882401 Free Books & Documents. Review.
A new GRPR peptide antagonist, DOTA-4-amino-1-carboxymethyl-piperidine-d-Phe-Gln-Trp-Ala-Val-Gly-His-Sta-Leu-NH(2) (RM2), has been found to have a higher affinity for GRPR than RM1 and has been labeled with (68)Ga for positron emission tomography (PET) imaging (6). 3-Cyano-4-[(18 …
A new GRPR peptide antagonist, DOTA-4-amino-1-carboxymethyl-piperidine-d-Phe-Gln-Trp-Ala-Val-Gly-His-Sta-Leu-NH(2) (RM2), has been found to …
Florbetaben F 18.
[No authors listed] [No authors listed] 2020 Aug 17. Drugs and Lactation Database (LactMed®) [Internet]. Bethesda (MD): National Institute of Child Health and Human Development; 2006–. 2020 Aug 17. Drugs and Lactation Database (LactMed®) [Internet]. Bethesda (MD): National Institute of Child Health and Human Development; 2006–. PMID: 29999993 Free Books & Documents. Review.
Information in this record refers to the use of florbetaben F 18 as a diagnostic agent. No information is available on the use of florbetaben F 18 during breastfeeding. The manufacturer recommends withholding breastfeeding for 24 hours after a diagnostic dose Twenty …
Information in this record refers to the use of florbetaben F 18 as a diagnostic agent. No information is available on the use of flo …
(4S)-4-(3-[(18)F]Fluoropropyl)-l-glutamate.
Chopra A. Chopra A. 2013 Mar 20 [updated 2013 May 23]. In: Molecular Imaging and Contrast Agent Database (MICAD) [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2004–2013. 2013 Mar 20 [updated 2013 May 23]. In: Molecular Imaging and Contrast Agent Database (MICAD) [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2004–2013. PMID: 23700646 Free Books & Documents. Review.
On the basis of the information described above, it was hypothesized that PET agents that target system x(c) can probably be used to visualize tumors that have an enhanced expression and activity of the antiporter (5). The (18)F-labeled structural analog of l-glutamate 4-[ …
On the basis of the information described above, it was hypothesized that PET agents that target system x(c) can probably be used to visuali …
Flotufolastat F 18: Diagnostic First Approval.
Heo YA. Heo YA. Mol Diagn Ther. 2023 Sep;27(5):631-636. doi: 10.1007/s40291-023-00665-y. Epub 2023 Jul 13. Mol Diagn Ther. 2023. PMID: 37439946 Review.
Flotufolastat F 18 (POSLUMA()) is an (18)F-labelled radiohybrid (rh) prostate-specific membrane antigen (PSMA)-targeted imaging agent being developed by Blue Earth Diagnostics, a subsidiary of Bracco Imaging, for prostate cancer imaging. ...This article summarizes t …
Flotufolastat F 18 (POSLUMA()) is an (18)F-labelled radiohybrid (rh) prostate-specific membrane antigen (PSMA)-targeted imagin …
Clotrimazole.
[No authors listed] [No authors listed] 2022 Sep 19. Drugs and Lactation Database (LactMed®) [Internet]. Bethesda (MD): National Institute of Child Health and Human Development; 2006–. 2022 Sep 19. Drugs and Lactation Database (LactMed®) [Internet]. Bethesda (MD): National Institute of Child Health and Human Development; 2006–. PMID: 30000270 Free Books & Documents. Review.
Piflufolastat F 18: Diagnostic First Approval.
Keam SJ. Keam SJ. Mol Diagn Ther. 2021 Sep;25(5):647-656. doi: 10.1007/s40291-021-00548-0. Epub 2021 Jul 22. Mol Diagn Ther. 2021. PMID: 34292532 Review.
Piflufolastat F 18 (PYLARIFY()) is an (18)F-labelled diagnostic imaging agent that has been developed by Progenics Pharmaceuticals Inc., a Lantheus company, for positron emission tomography (PET) that targets prostate-specific membrane antigen (PSMA). ...This articl …
Piflufolastat F 18 (PYLARIFY()) is an (18)F-labelled diagnostic imaging agent that has been developed by Progenics Pharmaceuti …
Luminescence Thermometry Based on the Upconversion Luminescence from the Stark Sublevels of BaY(2)F(8):Yb(3+), Tm(3+) Phosphor.
Sharma AK, Nair GB, Dhoble SJ, Kroon RE, Terblans JJ, Swart HC. Sharma AK, et al. J Fluoresc. 2023 Jul 14. doi: 10.1007/s10895-023-03295-z. Online ahead of print. J Fluoresc. 2023. PMID: 37450083
Visible and near-infrared (NIR) upconversion luminescence (UCL) emissions originating from the BaY(2)F(8): Yb(3+), Tm(3+) systems were investigated under a laser excitation at 980 nm. The BaY(2)F(8):20 mol% Yb(3+), x mol% Tm(3+) and BaY(2)F …
Visible and near-infrared (NIR) upconversion luminescence (UCL) emissions originating from the BaY(2)F(8): Yb(3+), Tm(3+) syst …
Efficient, diode-pumped Tm(3)+:BaY(2)F(8) vibronic laser.
Cornacchia F, Parisi D, Bernardini C, Toncelli A, Tonelli M. Cornacchia F, et al. Opt Express. 2004 May 3;12(9):1982-9. doi: 10.1364/opex.12.001982. Opt Express. 2004. PMID: 19475032 Free article.
In this work we report the spectroscopy and laser results of several Thulium doped BaY(2)F(8) single crystals grown using the Czochralski technique. ...
In this work we report the spectroscopy and laser results of several Thulium doped BaY(2)F(8) single crystals grown using the …
Upconversion process in BaY(2) F(8) :Yb(3+) ,Ho(3+) phosphor for optical thermometry.
Nair GB, Sharma AK, Dhoble SJ, Swart HC. Nair GB, et al. Luminescence. 2021 Dec;36(8):1847-1850. doi: 10.1002/bio.3923. Epub 2020 Aug 26. Luminescence. 2021. PMID: 32715611
A BaY(2) F(8) :Yb(3+) ,Ho(3+) phosphor was synthesized using a simple precipitation method. The temperature-sensing properties of BaY(2) F(8) :Yb(3+) ,Ho(3+) phosphor were investigated using the fluorescence intensity ratio (FIR) of the thermally coupl …
A BaY(2) F(8) :Yb(3+) ,Ho(3+) phosphor was synthesized using a simple precipitation method. The temperature-sensing properties …
Preclinical evaluation of BAY 1075553, a novel (18)F-labelled inhibitor of prostate-specific membrane antigen for PET imaging of prostate cancer.
Lesche R, Kettschau G, Gromov AV, Böhnke N, Borkowski S, Mönning U, Hegele-Hartung C, Döhr O, Dinkelborg LM, Graham K. Lesche R, et al. Eur J Nucl Med Mol Imaging. 2014 Jan;41(1):89-101. doi: 10.1007/s00259-013-2527-3. Epub 2013 Aug 17. Eur J Nucl Med Mol Imaging. 2014. PMID: 23955632
Fast clearance of BAY 1075553 resulted overall in low background signals in other organs except for high uptake into kidney and bladder which was mainly caused by renal elimination of BAY 1075553. ...BAY 1075553 can be produced using a robust, direct radiosyn …
Fast clearance of BAY 1075553 resulted overall in low background signals in other organs except for high uptake into kidney and bladd …
2,148 results